Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Background
Chronic subdural hematoma (CSDH) pathophysiology has undergone a paradigm shift from being regarded as solely traumatic to be driven mainly by inflammation. Human leucocyte antigen (HLA) is a gene complex involved in antigen processing and presentation to T lymphocytes, thereby mediating the adaptive immune responses. As specific HLA profiles are associated with inflammatory diseases, patients with a specific HLA profile may have a lower threshold for subdural inflammation, and therefore are predisposed for CSDH development.

We hypothesized that (1) CSDH patients have a specific HLA profile compared to a Danish background population, and (2) patients with recurrent CSDH have a specific HLA profile compared to CSDH patients without recurrent CSDH.

Methods
Three specific HLA class II haplotypes known to drive inflammatory-mediated diseases were determined in 68 patients with CSDH. The distribution of these three haplotypes in our CSDH population was compared to a Danish population of blood donors using Monte Carlo Pearson’s chi-square test. Furthermore, the distribution of the haplotypes was compared between CSDH patients with and without recurrent CSDH.

Results
We found no significant association between either of the haplotypes and the risk of CSDH, and neither of the haplotypes were associated with increased risk of CSDH recurrence.

Conclusion
This study did not show an association between selected HLA class II haplotypes and the risk of CSDH or recurrence of CSDH compared with a healthy background population.
OriginalsprogEngelsk
TidsskriftActa Neurochirurgica
Vol/bind165
Sider (fra-til)2399–2405
Antal sider7
ISSN0001-6268
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This study was funded by the Research Fund at the Department of Neurosurgery, Copenhagen University Hospital, Rigshospitalet.

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

ID: 362681598